ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

KERX Keryx Biopharmaceuticals, Inc. (delisted)

3.36
0.00 (0.00%)
06 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Keryx Biopharmaceuticals, Inc. (delisted) NASDAQ:KERX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.36 3.10 3.35 0 01:00:00

KERYX 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General & Kahn Swick & Foti, LLC Remin...

01/10/2016 3:07am

Business Wire


Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Keryx Biopharmaceuticals, Inc. (delisted) Charts.

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until October 3, 2016 to file lead plaintiff applications in a securities class action lawsuit against Keryx Biopharmaceuticals Inc. (NasdaqCM: KERX). Investor losses must relate to purchases of the Company’s common stock between February 25, 2016, and August 1, 2016. This action is pending in the United States District Court for the Southern District of New York.

What You May Do

If you purchased shares of Keryx and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by October 3, 2016.

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Kahn Swick & Foti, LLCLewis Kahn, Managing Partner, 877-515-1850lewis.kahn@ksfcounsel.com

1 Year Keryx Biopharmaceuticals, Inc. (delisted) Chart

1 Year Keryx Biopharmaceuticals, Inc. (delisted) Chart

1 Month Keryx Biopharmaceuticals, Inc. (delisted) Chart

1 Month Keryx Biopharmaceuticals, Inc. (delisted) Chart

Your Recent History

Delayed Upgrade Clock